Abstract:The RNA-guided endonucleases of the CRISPR-Cas9 system, including the most widely used Cas9 from Streptococcus pyogenes (SpCas9), are becoming a robust genome editing tool in model organisms and hold immense promise for therapeutic applications. Many strategies have been employed to overcome the limitations caused by SpCas9’s off-target effects and its stringent requirement for the protospacer adjacent motif (PAM) sequence. However, the structural mechanisms underlying these strategies remain undefined. Here, we present crystal structure of a SpCas9 variant, xCas9 3.7 that has broad PAM compatibility and high DNA targeting specificity, in complex with a single-guide RNA and its double-stranded DNA targets. Structural comparison revealed that salt bridge-stabilized R1335 is critical for the stringent selection of PAM sequence by SpCas9. Unrestricted rotamerization of this residue by the E1219V mutation in xCas9 3.7 lessens the stringency for PAM recognition and allows SpCas9 to recognize multiple PAM sequences as further supported by biochemical data. Compared to those in wild-type (WT) SpCas9, REC2 and REC3 domains in xCas9 3.7 undergo striking conformational changes, leading to reduced contact with DNA substrate. SpCas9 mutants engineered to display less interaction with DNA and have conformationally more flexible REC2 and REC3 domains display enhanced specificity for DNA substrates in both biochemical and cellular assays. Taken together, our findings reveal the structural mechanisms underlying the broadened PAM compatibility and high DNA fidelity of xCas9 3.7, which can assist rational engineering of more efficient SpCas9 variants and probably other Cas9 orthologs.

Engineer Chimeric Cas9 to Expand PAM Recognition Based on Evolutionary Information

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

Hybrid Cas12a Variants with Relaxed PAM Requirements Expand Genome Editing Compatibility

Compact SchCas9 Recognizes the Simple NNGR PAM

SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity Than SpCas9 or FnCpf1 in Human Cells.

Diverse noncanonical PAMs recognized by SpCas9 in human cells

Identification of SaCas9 orthologs containing a conserved serine residue that determines simple NNGG PAM recognition

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Expanding the CRISPR toolbox by engineering Cas12a orthologs of metagenomic discovery

Genome editing with natural and engineered CjCas9 orthologs

Exploring and engineering PAM-diverse Streptococci Cas9 for PAM-directed bifunctional and titratable gene control in bacteria

Efficient Cleavage Resolves PAM Preferences of CRISPR-Cas in Human Cells.

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM

Targeted Gene Disruption by CRISPR/xCas9 System in Drosophila Melanogaster.

Structural insights into a high fidelity variant of SpCas9

In-depth assessment of the PAM compatibility and editing activities of Cas9 variants

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences